Press Releases

June 24, 2008

Terumo Heart obtains IRB approval from the University of Michigan to Initiate DuraHeart Left Ventricular Assist System U.S. Pivotal Trial

April 22, 2008

Chisato Nojiri, M.D., Ph.D., Chief Executive Officer for Terumo Heart, Inc.. presented current European results of DuraHeart at ISHLT in April

March 3, 2008

Terumo Heart, Inc. announced today that they have received conditional approval from the Food and Drug Administration (FDA) to begin enrollment in the US Pivotal Trial of the DuraHeart ^TM LVAS for a Bridge-to-Transplant (BTT) indication.

September 17, 2007

Terumo Heart, Inc. announced today that it had a successful European Launch Symposium at the European Association of Cardio-Thoracic Surgeons (EACTS) meeting in Geneva, Switzerland.

September 5, 2007

Terumo Heart Inc. announced today that it is planning a European Launch Symposium at the European Association of Cardio-Thoracic Surgeons (EACTS) meeting in Geneva, Switzerland on September 17, 2007

February 27, 2007

Terumo Heart Inc. announced today that it has received a CE Mark allowing the commercial distribution of the DuraHeart® Left Ventricular Assist System within the European Community. The DuraHeart is the world’s first magnetically levitated centrifugal LVAS to receive market approval in Europe.